Clinical Trial Update: Effect of Stablor on Visceral Fat Loss in Patients With a Metabolic Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of Stablor on visceral fat loss in adults with metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Stablor

Snippet

Sponsor: Laboratoires Nutrition et Cardiometabolisme | Conditions: Metabolic Syndrome | NA | Status: COMPLETED